XLON
MHC
Market cap8mUSD
May 16, Last price
13.00GBP
1D
6.12%
1Q
-27.78%
Jan 2017
-95.25%
IPO
-100.00%
Name
Myhealthchecked PLC
Chart & Performance
P/E
—
P/S
61.63
EPS
—
Div Yield, %
—
Shrs. gr., 5y
37.55%
Rev. gr., 5y
368.99%
Revenues
11m
-50.81%
Net income
-159k
L
CFO
724k
-54.92%
Earnings
Jun 02, 2025
Profile
MyHealthChecked PLC develops and commercializes home healthcare and wellness tests in the United Kingdom. The company manufactures and supplies MyLotus, a testing strip. It also offers COVID-19 sample collection kit under the MyHealthChecked brand; and a range of at-home DNA and RNA tests. The company was formerly known as Concepta PLC and changed its name to MyHealthChecked PLC in December 2020. MyHealthChecked PLC was incorporated in 2008 and is headquartered in Cardiff, the United Kingdom.
IPO date
Jul 05, 2013
Employees
21
Domiciled in
GB
Incorporated in
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2016‑01 | |
| Income | |||||||||
Revenues | 10,977 -50.81% | 22,314 36.26% | |||||||
Cost of revenue | 11,647 | 21,408 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (670) | 906 | |||||||
NOPBT Margin | 4.06% | ||||||||
Operating Taxes | (36) | (724) | |||||||
Tax Rate | |||||||||
NOPAT | (634) | 1,630 | |||||||
Net income | (159) -107.10% | 2,241 44.77% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (25) | ||||||||
BB yield | 0.36% | ||||||||
| Debt | |||||||||
Debt current | 26 | 29 | |||||||
Long-term debt | 26 | 77 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | (7,697) | (7,502) | |||||||
| Cash flow | |||||||||
Cash from operating activities | 724 | 1,606 | |||||||
CAPEX | (567) | (338) | |||||||
Cash from investing activities | (531) | (338) | |||||||
Cash from financing activities | (52) | (47) | |||||||
FCF | (551) | 1,528 | |||||||
| Balance | |||||||||
Cash | 7,749 | 7,608 | |||||||
Long term investments | |||||||||
Excess cash | 7,200 | 6,492 | |||||||
Stockholders' equity | 14,748 | (8,352) | |||||||
Invested Capital | 1,530 | 17,125 | |||||||
ROIC | 9.65% | ||||||||
ROCE | 10.33% | ||||||||
| EV | |||||||||
Common stock shares outstanding | 51,971 | 51,882 | |||||||
Price | 0.13 -43.90% | 0.24 -32.99% | |||||||
Market cap | 6,886 -43.81% | 12,254 -29.92% | |||||||
EV | (811) | 4,752 | |||||||
EBITDA | (447) | 1,128 | |||||||
EV/EBITDA | 1.81 | 4.21 | |||||||
Interest | 2 | 5 | |||||||
Interest/NOPBT | 0.55% | ||||||||